Postmarketing surveillance of rabeprazole in upper gastrointestinal peptic lesions in Japanese patients with coexisting hepatic disorders.

PubWeight™: 0.75^‹?›

🔗 View Article (PMC 3965972)

Published in Curr Ther Res Clin Exp on January 01, 2006

Authors

Isao Makino¹, Kimihide Nakamura¹, Yoichi Sato¹, Yuzuru Sato², Shuichi Sezai², Yusei Ikeda³, Wahei Shinmura³, Hajime Watahiki⁴, Hideaki Yamamoto⁴, Yayuki Hioki⁴, Masao Suzuki⁴, Takashi Kumada⁵, Takashi Honda⁵, Tomoo Rikitoku⁵, Yasuhiro Hisanaga⁵, Hiroshi Fukui⁶, Junichi Yamao⁶, Hironaka Kawasaki⁷, Akihide Hosoda⁷, Morikazu Onji⁸, Hidetaka Matsui⁸, Michio Sata⁹, Takuji Torimura⁹, Kazuhiko Oho⁹, Ryuichiro Maekawa¹⁰, Yoshiyuki Takagi¹⁰, Satoshi Shakado¹⁰, Masafumi Nakayama¹⁰, Kazuhisa Gondo¹¹, Hirofumi Fukushima¹², Taku Kusaba¹², Hirohito Tsubouchi¹³, Katsuhiro Hayashi¹³, Takeshi Hori¹³, Yozo Iida¹⁴, Kouki Yutoku¹⁴, Noboru Maetani¹⁴, Yoshitsugu Kubo¹⁴, Yoshifumi Miyata¹⁵

Author Affiliations

1: Second Department of Internal Medicine, Asahikawa Medical College, Hokkaido, Japan.
2: Division of Gastroenterology, Kanto Medical Center NTT EC, Tokyo, Japan.
3: Department of Internal Medicine, Tokyo- Kosei-nenkin Hospital, Tokyo, Japan.
4: Department of Gastroenterology, Seirei Mikatahara General Hospital, Shizuoka, Japan.
5: Department of Gastroenterology, Ogaki Municipal Hospital, Gifu, Japan.
6: Third Department of Internal Medicine, Nora Medical University, Nora, Japan.
7: Second Department of Internal Medicine, Faculty of Medicine, Tottori University, Tottori, Japan.
8: Third Department of Internal Medicine, Faculty of Medicine, Ehime University, Ehime, Japan.
9: Second Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan.
10: Department of Internal Medicine, Social Insurance Tagawa Hospital, Fukuoka, Japan.
11: Department of Internal Medicine, Fukuoka Prefectural Yanagawa Hospital, Fukuoka, Japan.
12: Department of Internal Medicine, Fukuokaken Saiseikai Futsukaichi Hospital, Fukuoka, Japan.
13: Department of Internal Medicine, Miyazaki Medical College Hospital, Miyazaki, Japan.
14: Department of Gastroenterology, Kokura Memorial Hospital, Fukuoka, Japan.
15: Department of Internal Medicine, Chubu Hospital, Miyazaki, Japan.

Articles cited by this ↗

The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology (1996) 4.69

Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut (1985) 2.20

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole. Aliment Pharmacol Ther (1999) 1.98

Portal hypertensive gastric mucosa: an endoscopic study. Gut (1986) 1.79

A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom. Pharmacotherapy (1997) 1.55

Endoscopic measurement of gastric mucosal blood flow with special reference to the effect of sclerotherapy in patients with liver cirrhosis. Am J Gastroenterol (1990) 1.55

Gastric secretion in human hepatic cirrhosis. Gastroenterology (1960) 1.21

Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital. Gastroenterology (1990) 1.11

Endogenous prostaglandin E2 in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension. Gastroenterology (1987) 1.02

The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs. Br J Clin Pharmacol (1997) 1.00

A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years. Aliment Pharmacol Ther (2003) 0.85

Functional study of the gastric mucosal barrier in hepatic cirrhosis. Acta Hepatogastroenterol (Stuttg) (1976) 0.84

Gastric mucus generation in cirrhotic patients with portal hypertension. Effects of tetraprenylacetone. Dig Dis Sci (1996) 0.82

Rabeprazole: pharmacokinetics in patients with stable, compensated cirrhosis. Clin Ther (1999) 0.82

Endoscopic, histologic and haemodynamic studies on portal hypertensive gastric mucosa. J Gastroenterol Hepatol (1989) 0.81

Gastric mucosal microcirculatory disturbances in portal hypertension. J Gastroenterol Hepatol (1989) 0.79

[Gastroduodenal lesions in patients with liver cirrhosis--pathogenesis and management]. Nihon Rinsho (1994) 0.78

Articles by these authors ⇆

Tumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCC. Liver Cancer (2015) 1.10

Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil. Liver Cancer (2015) 0.79

Protein and glycomic plasma markers for early detection of adenoma and colon cancer. Gut (2016) 0.75

Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan. J Gastroenterol (2017) 0.75

Adjuvant hepatic artery infusion chemotherapy after hemihepatectomy for gastric cancer liver metastases. Int J Surg (2017) 0.75